Vitiligo clinical trials at UC Irvine
3 research studies open to eligible people
AMG 714 for Vitiligo
open to eligible people ages 18-75
This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.
Irvine, California and other locations
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
open to eligible people ages 18 years and up
To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
Irvine, California and other locations
Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
open to all eligible people
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Irvine, California and other locations
Our lead scientists for Vitiligo research studies include Anand Ganesan, MD, PhD Natasha Mesinkovska, MD.
Last updated: